{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:34:31Z","timestamp":1772138071986,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Mayo Foundation and NIH","award":["AI-31155"],"award-info":[{"award-number":["AI-31155"]}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2014-04234"],"award-info":[{"award-number":["RGPIN-2014-04234"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centre de Proteomique Structurale et Fonctionnelle des Proteomes"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.toxlet.2017.10.012","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T20:47:10Z","timestamp":1508014030000},"page":"71-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Structure determination of disease associated peak AAA from l -Tryptophan implicated in the eosinophilia-myalgia syndrome"],"prefix":"10.1016","volume":"282","author":[{"given":"Klaus","family":"Klarskov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Luc","family":"Boudreault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Normandin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baptiste","family":"Plancq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Marsault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald J.","family":"Gleich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2017.10.012_bib0005","unstructured":"Akashiba, T., Nakayama, A. and Murata, A., (1982). Process for Producing L- Tryptophan, A Pure Culture of a Microorganism Strain used in Said Process. USA Patent 4,363,875. December 14th, 1982."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/282574","article-title":"Electrospray ionization mass spectrometry: a technique to access information beyond the molecular weight of the analyte","author":"Banerjee","year":"2012","journal-title":"Int. J. Analy. Chem."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199008093230601","article-title":"An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use","volume":"323","author":"Belongia","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.nu.12.070192.001315","article-title":"The eosinophilia myalgia syndrome and tryptophan","volume":"12","author":"Belongia","year":"1992","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0025","series-title":"Cases in Field Epidemiology: A Global Perspective","first-page":"313","article-title":"Toxic Tryptophan? investigating the Eosinophilia-Myalgia syndrome in minnesota","author":"Belongia","year":"2004"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0030","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1099\/00221287-137-3-587","article-title":"Factors affecting the normal and branched-chain moieties of teicoplanin components produced by Actinoplanes teichomyceticus","volume":"137","author":"Borghi","year":"1991","journal-title":"J. Gen. Microbiol."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0035","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.jasms.2010.06.006","article-title":"Accurate mass measurement: terminology and treatment of data","volume":"21","author":"Brenton","year":"2010","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0040","series-title":"Lipid Analysis\u2013Isolation, Separation, Identification and Lipidomic Analysis","author":"Christie","year":"2010"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0045","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1039\/C5NP00073D","article-title":"Fragmentation reactions using electrospray ionization mass spectrometry: an important tool for the structural elucidation and characterization of synthetic and natural products","volume":"33","author":"Demarque","year":"2016","journal-title":"Nat. Prod. Rep."},{"issue":"46","key":"10.1016\/j.toxlet.2017.10.012_bib0050","article-title":"Current and future perspectives on the structural identification of small molecules in biological systems","volume":"6","author":"Dias","year":"2016","journal-title":"Metabolites"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0055","first-page":"813","article-title":"Role of fatty acids in Bacillus environmental adaptation","volume":"6","author":"Diomande","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0060","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0140-6736(90)90421-Z","article-title":"L-tryptophan and eosinophilia-myalgia syndrome in new Mexico","volume":"335","author":"Eidson","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0065","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1021\/jp0374915","article-title":"Gas-phase fragmentation reactions of protonated aromatic amino acids: concomitant and consecutive neutral eliminations and radical cation formations","volume":"108","author":"El Aribi","year":"2004","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0070","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1248\/cpb.40.2236","article-title":"3-Anilino-L-Alanine structural determination of UV-5, a contaminant in EMS-associated L-Tryptophan samples","volume":"40","author":"Goda","year":"1992","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0075","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jasms.2004.11.008","article-title":"A new charge-associated mechanism to account for the production of fragment ions in the high-energy CID spectra of fatty acids","volume":"16","author":"Harvey","year":"2005","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0080","doi-asserted-by":"crossref","first-page":"1683-1687","DOI":"10.1016\/j.chroma.2010.01.036","article-title":"Structure and absolute configuration of an unsaturated anteiso fatty acid from Bacillus megaterium","volume":"1217","author":"Hauff","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0085","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM199003293221301","article-title":"Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan","volume":"322","author":"Hertzman","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0090","first-page":"867","article-title":"The eosinophilia-myalgia syndrome: the los alamos conference","volume":"18","author":"Hertzman","year":"1991","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0095","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1001\/archinte.161.19.2301","article-title":"Rigorous new approach to constructing a gold standard for validating new diagnostic criteria, as exemplified by the Eosinophilia-Myalgia syndrome","volume":"161","author":"Hertzman","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00230724","article-title":"Contaminants in L- tryptophan associated with eosinophilia- myalgia syndrome","volume":"25","author":"Hill","year":"1993","journal-title":"Arch. Environ. Contam. Toxicol."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7171\/jbt.13-2404-005","article-title":"The use of ammonium formate as a mobile-phase modifier for LC\u2013MS\/MS analysis of tryptic digests","volume":"24","author":"Johnson","year":"2013","journal-title":"J. Biomol. Tech."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0110","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1128\/MMBR.55.2.288-302.1991","article-title":"Iso- and anteiso-fatty acids in bacteria: biosynthesis function, and taxonomic significance","volume":"55","author":"Kaneda","year":"1991","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/oxfordjournals.epirev.a036085","article-title":"Eosinophilia-myalgia syndrome: coming to grips with a new illness","volume":"14","author":"Kilbourne","year":"1992","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0120","series-title":"48th American Society for Mass Spectrometry and Allied Topics Meeting","article-title":"Structural of a contaminant in L-tryptophan associated with eosinophilia-myalgia syndrome","author":"Klarskov","year":"2000"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0125","series-title":"Fatty Acid Homologs of L-Tryptophan Contaminants Present in the Dietary Supplement Associated with the Onset of Eosinophilia- Myalgia Syndrome","author":"Klarskov","year":"2017"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jasms.2003.09.011","article-title":"Gas-phase reactions of protonated tryptophan","volume":"15","author":"Lioe","year":"2004","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7326\/0003-4819-113-2-124","article-title":"The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. clinical features in 20 patients and aspects of pathophysiology","volume":"113","author":"Martin","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0140","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0167-7799(94)90035-3","article-title":"The eosinophilia-myalgia syndrome and tryptophan production: a cautionary tale","volume":"12","author":"Mayeno","year":"1994","journal-title":"Trends Biotech."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0145","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1126\/science.2270484","article-title":"Characterization of \u2018Peak E\u2019: a novel amino acid associated with eosinophilia-myalgia syndrome","volume":"250","author":"Mayeno","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0150","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0025-6196(12)61142-2","article-title":"3- (Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalagia syndrome: a link to the toxic oil syndrome?","volume":"67","author":"Mayeno","year":"1992","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0155","first-page":"350","article-title":"Characterization of by-products in L-tryptophan","volume":"14","author":"Muller","year":"1991","journal-title":"Bioforum"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0160","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/873081","article-title":"Response mechanisms of bacterial degraders to environmental contaminants on the level of cell walls and cytoplasmic membrane","volume":"2014","author":"Mur\u00ednov\u00e1","year":"2014","journal-title":"Int. J. Microbiol."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0165","series-title":"Tandem Mass Spectrometry of Lipids: Molecular Analysis of Complex Lipids","author":"Murphy","year":"2015"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0170","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/metabo3020312","article-title":"Applying tandem mass spectral libraries for solving the critical assessment of small molecule identification (CASMI) LC\/MS challenge 2012","volume":"3","author":"Oberacher","year":"2013","journal-title":"Metabolites"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0175","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/ci300563h","article-title":"ChemCalc: a building block for tomorrow\u2019s chemical infrastructure","volume":"53","author":"Patiny","year":"2013","journal-title":"J. Chem. Int. Model"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/oxfordjournals.aje.a116841","article-title":"Tryptophan contaminants associated with eosinophilia-myalgia syndrome","volume":"138","author":"Philen","year":"1993","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0185","first-page":"19","article-title":"Principles and applications of liquid chromatography- mass spectrometry in clinical biochemistry","volume":"30","author":"Pitt","year":"2009","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1194\/jlr.D020651","article-title":"Structural characterization of saturated branched chain fatty acid methyl esters by collisional dissociation of molecular ions generated by electron ionization","volume":"53","author":"Ran-Ressler","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0195","first-page":"469","article-title":"Synthesis, formation and occurrence of contaminants in biotechnologically manufactured L- tryptophan","volume":"vol. 467","author":"Simat","year":"1999"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0200","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jama.1990.03450020065028","article-title":"Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer","volume":"264","author":"Slutsker","year":"1990","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0205","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0040-4039(00)74469-8","article-title":"1,1\u2019-Ethyl-idenebis(L- tryptophan), structure determination of contaminant \u201897\u2019-implicated in the eosinophilia-myalgia syndrome (EMS)","volume":"32","author":"Smith","year":"1991","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0210","series-title":"Practical HPLC Method Development","author":"Snyder","year":"2012"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0215","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1001\/jama.1990.03450130070029","article-title":"Eosinophilia-myalgia syndrome: results of national surveillance","volume":"264","author":"Swygert","year":"1990","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0220","first-page":"1711","article-title":"Eosinophilia-myalgia syndrome: mortality data from the US national surveillance system","volume":"20","author":"Swygert","year":"1993","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0225","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1248\/cpb.39.820","article-title":"Characterization of contaminants in EMS-associated L-tryptophan samples by high performance liquid chromatography","volume":"39","author":"Toyo\u2019oka","year":"1991","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0230","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0021-9673(93)80450-M","article-title":"Separation and isolation of trace impurities in L- tryptophan by high performance liquid chromatography","volume":"630","author":"Trucksess","year":"1993","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0235","series-title":"COT Statement on Tryptophan and the Eosinophilia-Myalgia Syndrome","author":"UK Committee on Toxicology (COT)","year":"2004"},{"key":"10.1016\/j.toxlet.2017.10.012_bib0240","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.1038\/jid.1993.31","article-title":"L-Tryptophan and the eosinophilia- myalgia syndrome: current understanding of the etiology and pathogenesis","volume":"100","author":"Varga","year":"1993","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0245","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-4274(97)00048-9","article-title":"On-line HPLC tandem mass spectrometry analysis of contaminants of L-tryptophan associated with the onset of the eosinophilia- myalgia syndrome","volume":"92","author":"Williamson","year":"1997","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2017.10.012_bib0250","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-4274(98)00223-9","article-title":"On-line HPLC tandem mass spectrometry structural characterization of case-associated contaminants of L-tryptophan implicated with the onset of eosinophilia-myalgia syndrome","volume":"99","author":"Williamson","year":"1998","journal-title":"Toxicol. Lett."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427417314248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427417314248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T17:05:52Z","timestamp":1659632752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427417314248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":50,"alternative-id":["S0378427417314248"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2017.10.012","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure determination of disease associated peak AAA from l-Tryptophan implicated in the eosinophilia-myalgia syndrome","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2017.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}